ProShare Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $380K | Sell |
|
|||||
|
2025
Q2 | $428K | Buy |
|
|||||
|
2025
Q1 | $382K | Sell |
|
|||||
|
2024
Q4 | $596K | Buy |
|
|||||
|
2024
Q3 | $404K | Buy |
|
|||||
|
2024
Q2 | $247K | Sell |
|
|||||
|
2024
Q1 | $408K | Buy |
|
|||||
|
2023
Q4 | $354K | Buy |
|
|||||
|
2023
Q3 | $238K | Buy |
|
|||||
|
2023
Q2 | $222K | Buy |
|
|||||
|
2023
Q1 | $192K | Sell |
|
|||||
|
2022
Q4 | $251K | Buy |
|
|||||
|
2022
Q3 | $308K | Buy |
|
|||||
|
2022
Q2 | $227K | Sell |
|
|||||
|
2022
Q1 | $272K | Sell |
|
|||||
|
2021
Q4 | $816K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $200K | Buy |
|